Can see your point all 3 are a bit different, I guess what I'm trying to say is I think these guys seem to have something over and above the average biotech.
The sector is a real mix and some seem to have more of a claim of really having something above others.
There have been some huge rerates and one of the most ironic things is being real or having a real crack you actually have to legitimately work through the time frames of no news and seeing the price suffer through impatient sellers.
In terms of the selling since the CEO resignation that seems to have been very sustained.
Why the relentless selling? CEO leaving is a big no no normally, due you think people are being too rigid in their thinking and case of one sheep following another?
1AD Price at posting:
12.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)